MGO One Seven’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.5K Sell
19,826
-1,436
-7% -$2.96K ﹤0.01% 1396
2025
Q4
$42.1K Buy
21,262
+4,623
+28% +$14.8K ﹤0.01% 1384
2025
Q3
$48.4K Sell
16,639
-118
-0.7% -$271 ﹤0.01% 1314
2025
Q2
$30.3K Buy
16,757
+1,309
+8% +$2.33K ﹤0.01% 1188
2025
Q1
$23.2K Buy
15,448
+127
+0.8% +$320 ﹤0.01% 1088
2024
Q4
$36.2K Buy
15,321
+327
+2% +$5.74K ﹤0.01% 1059
2024
Q3
$441K Buy
14,994
+2,117
+16% +$48.8K 0.02% 625
2024
Q2
$159K Buy
+12,877
New +$271K 0.01% 923
2022
Q4
Sell
-5,432
Closed -$227 779
2022
Q3
$227 Buy
+5,432
New +$147K 0.01% 616

Other funds holding FLNA

MGO One Seven's FLNA Position: Q1 2026 in Review

MGO One Seven reduced its Filana Therapeutics (FLNA) stake by 6.8% in Q1 2026, selling an estimated $2.96K and leaving 19,826 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1396.

MGO One Seven first reported a position in FLNA in Q3 2022 and has held it in 9 quarters since. The position peaked at $441K in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • MGO One Seven held 19,826 shares of Filana Therapeutics worth $33.5K as of Q1 2026.
  • MGO One Seven sold 1,436 Filana Therapeutics shares in Q1 2026, an estimated $2.96K.
  • Filana Therapeutics made up ﹤0.01% of MGO One Seven's portfolio in Q1 2026, its #1396 holding.
  • MGO One Seven first reported a position in Filana Therapeutics in Q3 2022 and has held it in 9 quarters since.
  • MGO One Seven's Filana Therapeutics position peaked at $441K in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on MGO One Seven's 13F filing for Q1 2026, filed 14 May 2026.